These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

679 related articles for article (PubMed ID: 20808297)

  • 1. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort.
    Vavricka SR; Brun L; Ballabeni P; Pittet V; Prinz Vavricka BM; Zeitz J; Rogler G; Schoepfer AM
    Am J Gastroenterol; 2011 Jan; 106(1):110-9. PubMed ID: 20808297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular Manifestations in Inflammatory Bowel Disease Are Associated with Other Extra-intestinal Manifestations, Gender, and Genes Implicated in Other Immune-related Traits.
    Taleban S; Li D; Targan SR; Ippoliti A; Brant SR; Cho JH; Duerr RH; Rioux JD; Silverberg MS; Vasiliauskas EA; Rotter JI; Haritunians T; Shih DQ; Dubinsky M; Melmed GY; McGovern DP
    J Crohns Colitis; 2016 Jan; 10(1):43-9. PubMed ID: 26449790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-inflammatory joint pain in patients with inflammatory bowel disease is prevalent and has a significant impact on health related quality of life.
    Palm Ø; Bernklev T; Moum B; Gran JT
    J Rheumatol; 2005 Sep; 32(9):1755-9. PubMed ID: 16142874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-1 receptor antagonist (IL-1Ra) gene polymorphism in patients with inflammatory bowel disease in India.
    Mittal RD; Bid HK; Ghoshal UC
    Scand J Gastroenterol; 2005 Jul; 40(7):827-31. PubMed ID: 16109659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change of diagnosis during the first five years after onset of inflammatory bowel disease: results of a prospective follow-up study (the IBSEN Study).
    Henriksen M; Jahnsen J; Lygren I; Sauar J; Schulz T; Stray N; Vatn MH; Moum B;
    Scand J Gastroenterol; 2006 Sep; 41(9):1037-43. PubMed ID: 16938716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is inflammatory bowel disease more severe when it appears at younger ages?
    Rogler G
    Digestion; 2010; 81(4):235-6. PubMed ID: 20110708
    [No Abstract]   [Full Text] [Related]  

  • 7. The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study.
    Ott C; Obermeier F; Thieler S; Kemptner D; Bauer A; Schölmerich J; Rogler G; Timmer A
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):917-23. PubMed ID: 18794607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of juvenile-onset inflammatory bowel disease in central Saudi Arabia.
    El Mouzan MI; Abdullah AM; Al Habbal MT
    J Trop Pediatr; 2006 Feb; 52(1):69-71. PubMed ID: 15947013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study.
    Bernstein CN; Blanchard JF; Rawsthorne P; Yu N
    Am J Gastroenterol; 2001 Apr; 96(4):1116-22. PubMed ID: 11316157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database.
    Vind I; Riis L; Jess T; Knudsen E; Pedersen N; Elkjaer M; Bak Andersen I; Wewer V; Nørregaard P; Moesgaard F; Bendtsen F; Munkholm P;
    Am J Gastroenterol; 2006 Jun; 101(6):1274-82. PubMed ID: 16771949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Extra-intestinal manifestation of IBD in Veszprém county (of Hungary): results of a 25-years follow-up study].
    Lakatos L; Pandur T; Dávid G; Balogh Z; Küronya P; Tollas A; Lakatos PL
    Orv Hetil; 2003 Oct; 144(40):1965-75. PubMed ID: 14626638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Risk of Later Diagnosis of Inflammatory Bowel Disease in Patients With Dermatological Disorders Associated With Inflammatory Bowel Disease.
    King D; Chandan JS; Thomas T; Nirantharakumar K; Reulen RC; Adderley NJ; Trudgill N
    Inflamm Bowel Dis; 2021 Oct; 27(11):1731-1739. PubMed ID: 34669933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Clostridium difficile on inflammatory bowel disease.
    Issa M; Vijayapal A; Graham MB; Beaulieu DB; Otterson MF; Lundeen S; Skaros S; Weber LR; Komorowski RA; Knox JF; Emmons J; Bajaj JS; Binion DG
    Clin Gastroenterol Hepatol; 2007 Mar; 5(3):345-51. PubMed ID: 17368234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age at disease onset of inflammatory bowel disease is associated with later extraintestinal manifestations and complications.
    Herzog D; Fournier N; Buehr P; Rueger V; Koller R; Heyland K; Nydegger A; Spalinger J; Schibli S; Petit LM; Braegger CP;
    Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):598-607. PubMed ID: 29360691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort.
    Vavricka SR; Rogler G; Gantenbein C; Spoerri M; Prinz Vavricka M; Navarini AA; French LE; Safroneeva E; Fournier N; Straumann A; Froehlich F; Fried M; Michetti P; Seibold F; Lakatos PL; Peyrin-Biroulet L; Schoepfer AM
    Inflamm Bowel Dis; 2015 Aug; 21(8):1794-800. PubMed ID: 26020601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous manifestations in inflammatory bowel disease.
    Tromm A; May D; Almus E; Voigt E; Greving I; Schwegler U; Griga T
    Z Gastroenterol; 2001 Feb; 39(2):137-44. PubMed ID: 11253504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospitalization, surgery, and readmission rates of IBD in Canada: a population-based study.
    Bernstein CN; Nabalamba A
    Am J Gastroenterol; 2006 Jan; 101(1):110-8. PubMed ID: 16405542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and Characteristics of Extra-intestinal Manifestations in a Large Cohort of Greek Patients with Inflammatory Bowel Disease.
    Karmiris K; Avgerinos A; Tavernaraki A; Zeglinas C; Karatzas P; Koukouratos T; Oikonomou KA; Kostas A; Zampeli E; Papadopoulos V; Theodoropoulou A; Viazis N; Polymeros D; Michopoulos S; Bamias G; Kapsoritakis A; Karamanolis DG; Mantzaris GJ; Tzathas C; Koutroubakis IE
    J Crohns Colitis; 2016 Apr; 10(4):429-36. PubMed ID: 26721936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and prevalence of extraintestinal manifestations in a cohort of patients with inflammatory intestinal disease in Medellin, Colombia.
    Juliao-Baños F; Arrubla M; Osorio L; Camargo J; Londoño J; Cáceres C; Carvajal J; Mosquera-Klinger G; Donado J
    Gastroenterol Hepatol; 2021; 44(6):398-404. PubMed ID: 33172691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extraintestinal manifestations in inflammatory bowel disease: Prevalence and predictors in Indian patients.
    Bandyopadhyay D; Bandyopadhyay S; Ghosh P; De A; Bhattacharya A; Dhali GK; Das K
    Indian J Gastroenterol; 2015 Sep; 34(5):387-94. PubMed ID: 26614005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.